CTOs on the Move

Biolinq

www.biolinq.me

 
Biolinq develops skin-applied electrochemical sensors that analyze body fluids to provide actionable health information. Get blood level info, without accessing blood.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Biolinq raised $10M on 11/27/2017

Similar Companies

Owlet Baby Care

The world`s first infant health tracker, designed to notify you if your baby`s heart rate or oxygen levels fall out of range. Rest assured with Owlet.

Impedimed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.

RefleXion Medical

RefleXion Medical is on a mission to create a new cancer treatment modality through biological guidance.

Active Implants Corporation

Active Implants Corporation is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avation Medical

Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient`s own physiologic response. The Company`s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical application by eliminating need for surgery, needles and permanent implants and shifting therapy into the home environment.